Nurix Therapeutics, Inc.
Industry: Life Sciences ・ $NRIX on Nasdaq
Insider Sale
+$74,058
-6.19%
Shares
Shares Volume: 3,690 Shares
Average Share Price: $20.07
INSIDER
Hansen Gwenn
Chief Scientific Officer (Officer)
reported on Jan 30 2025
traded on Jan 30 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 55,937 |
PURCHASES/SALES 1Y | 0 / 4 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $63,046.26 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
PURCHASES/SALES 1Y | 0 / 31 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $106,013.3 |
COMPANY PREVIOUS TRADES |